1 / 14

Cancer Tumor Profiling Market Size Historical Growth, Analysis, Opportunities

Increasing demand for tumor profiling and diagnosis and therapy techniques is driven by oncologists. Increased use of biomarkers in tumor profiling and increasing use of next-generation cancer profiling sequencing methods are some of the main factors driving the growth of the tumor profiling market. Tumor profiling is used to evaluate the metabolism, properties, and mutations of the tumor that can assist discover effective therapies. Drugs that target these mutated kinases can be discovered and developed based on genetic modification.

jyotipolaris
Download Presentation

Cancer Tumor Profiling Market Size Historical Growth, Analysis, Opportunities

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer/Tumor Profiling Market Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15%

  2. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 “According to Polaris Market Research report, Cancer/Tumor Profiling market is witnessing major innovations & transformations and is anticipated to reach $15.32 Billion By 2027, registering a CAGR of 7.15% during the forecast period 2020 To 2027.” The global Cancer/Tumor Profiling market report sheds light on the key dynamics of the global market, analyzing the data on a historical basis and forecasted data till the year 2027. The market analysis covered in the report includes data in terms of value $15.32 Billion. The market overview section of the report covers the global industry overview, microeconomic and macroeconomic outlook, and forecasted factors. The market dynamics section of this report includes major drivers, restraints, trends, and opportunities emerging in the market. Cancer/Tumor Profiling Market Report Scope: The global Cancer/Tumor Profiling market is segmented based on product/service type, end-use, and region. The motive of the research report is to define market dynamics of different countries & segments in the recent time and to forecast the values for the coming years. The report is specifically designed to incorporate quantitative and qualitative aspects of the market within each country and region involved in the study. The report caters the extensive information regarding the driving factors & hurdles that will define the future outlook for the market. Additionally, the report also incorporates prevailing and emerging opportunities for stakeholders to invest along with the in-depth detailed analysis of product/services offerings of prominent players shaping the overall development of the market. - 2 -

  3. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 By Technology By Cancer Type By Biomarker By Application By Region Type •Immunoassay •NGS •PCR •In Situ Hybridization •Microarray •Mass Spectrometry •Others •Breast •Lung •Colorectal •Prostate •Melanoma •Others •Genomic Biomarkers •Protein Biomarkers •Others •Personalized Medicine •Diagnostics •Prognostics •Biomarker Discovery •Research •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) COVID-19 Impact Analysis for Cancer/Tumor Profiling Market COVID-19 is an ongoing public health emergency that has impacted almost all industries globally, and its long- term effects are expected to influence the target industry growth over the forecast period. Our ongoing research features the COVID-19 impact analysis section as a key part of the report to uncover the major issues and potential paths forward. In this report, the insights provided in terms of changes in consumer behavior and purchasing patterns, dynamics of current market forces, re-routing of the supply chain, and the interventions of governments. The latest study incorporates analysis, estimations, insights, and forecasts, considering the COVID-19 impact on the market. Browse Detailed Research Report On Cancer/Tumor Profiling Market Analysis: https://www.polarismarketresearch.com/industry-analysis/cancer-tumor-profiling-market Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Cancer/Tumor Profiling market in different regions and how leading players are forming strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities - 3 -

  4. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 Regional Outlook Among regional markets, the region emerged as the promising regional market with its higher revenue share contribution. The growth in this regional market is primarily attributed to the ongoing technological advancements in the industry, increasing economic stability, huge government investments, and growing awareness related to the benefits of the product/service. Competitive Landscape The report offers a complete industry analysis while featuring the competitive landscape that includes company financials, product portfolios, major breakthroughs, and upcoming projects. The report includes a detailed view of the global market, along with changing scenarios, trends, regional segmentation, regional landscape, major investments, and details of historical, present, and projected revenues. According to Polaris Market Research, the key players with a noteworthy dominance in the Cancer/Tumor Profiling market include Abott Molecular, Agendia, Boreal Genomics Inc, BD Biosciences, Caris Life Sciences, F. Hoffmann-La Roche Ltd, Foundation Medicine, Genscript Biotech Corporation, Guardant Health, Inc., Helomics Corporation, Histogene X, Hologic, Inc., HTG Molecular Diagnostics, Inc., Illumina, Inc., Nanostring Technologies, Inc., Neogenomics, Inc., Omniseq, Perthera, Qiagen N.V., Ribomed Biotechnologies, Inc., Roche Molecular Systems Inc., Sysmex Corporation and Tempus Labs. Request for sample: https://www.polarismarketresearch.com/industry-analysis/cancer-tumor-profiling-market/request-for- sample Table of Contents 1.Overview and Scope Overview and Scope 1.1.Research goal & scope 1.2.Research assumptions 1.3.Research Methodology 1.3.1.Primary data sources 1.3.2.Secondary data sources 1.4.Key take-aways 1.5.Stakeholders 2.Executive Summary Executive Summary 2.1.Market Definition 2.2.Market Segmentation 3.Cancer/tumor Profiling Market Insights Cancer/tumor Profiling Market Insights 3.1.Cancer/tumor Profiling– Industry snapshot 3.2.Cancer/tumor Profiling market dynamics - 4 -

  5. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 3.2.1.Cancer/tumor Profiling– Market Forces 3.2.1.1. Cancer/tumor Profiling Market driver analysis 3.2.1.2. Cancer/tumor Profiling Market restraint/challenges analysis 3.2.1.3. Cancer/tumor Profiling Market opportunity analysis 3.3.Industry analysis - Porter's five force 3.3.1.Bargaining power of supplier 3.3.2.Bargaining power of buyer 3.3.3.Threat of substitute 3.3.4.Threat of new entrant 3.3.5.Degree of competition 3.4.Cancer/tumor Profiling market PEST analysis 3.5.Value Chain Analysis 3.6.Competitive Ranking Analysis, 2019 4.Cancer/tumor Profiling Market Size and Forecast by Transducer Frequency Range Cancer/tumor Profiling Market Size and Forecast by Transducer Frequency Range 4.1.Global Cancer/tumor Profiling market share by technology, 2019 & 2027 4.2.Immunoassay 4.2.1.Global Immunoassay market estimates and forecasts, 2016 - 2027 (USD Million) 4.2.2.Global Immunoassay market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.3.Next Generation Sequencing (NGS) 4.3.1.Global NGS market estimates and forecasts, 2016 - 2027 (USD Million) 4.3.2.Global NGS market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.4.Polymerase Chain Reaction (PCR) 4.4.1.Global PCR market estimates and forecasts, 2016 - 2027 (USD Million) 4.4.2.Global PCR market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.5.In Situ Hybridization 4.5.1.Global In Situ Hybridization market estimates and forecasts, 2016 - 2027 (USD Million) 4.5.2.Global In Situ Hybridization market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.6.Microarray 4.6.1.Global Microarray market estimates and forecasts, 2016 - 2027 (USD Million) 4.6.2.Global Microarray market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.7.Mass Spectrometry 4.7.1.Global Mass Spectrometry market estimates and forecasts, 2016 - 2027 (USD Million) 4.7.2.Global Mass Spectrometry market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.8.Other Technology 4.8.1.Global Other Technology market estimates and forecasts, 2016 - 2027 (USD Million) 4.8.2.Global Other Technology market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.Cancer/tumor Profiling Market Size and Cancer/tumor Profiling Market Size and Forecast by Cancer Type Forecast by Cancer Type 5.1.Global Cancer/tumor Profiling market share by cancer type, 2019 & 2027 5.2.Breast Cancer 5.2.1.Global breast cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) - 5 -

  6. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 5.2.2.Global breast cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.3.Lung Cancer 5.3.1.Global lung cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.3.2.Global lung cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.4.Colorectal Cancer 5.4.1.Global colorectal cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.4.2.Global colorectal cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.5.Prostate Cancer 5.5.1.Global prostate cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.5.2.Global prostate cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.6.Melanoma Cancer 5.6.1.Global Melanoma cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.6.2.Global melanoma cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.7.Other Cancer 5.7.1.Global other cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.7.2.Global other cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 6.Cancer/tumor Profiling Market Size and Forecast by Biomarker Type Cancer/tumor Profiling Market Size and Forecast by Biomarker Type 6.1.Global Cancer/tumor Profiling market share by biomarker type, 2019 & 2027 6.2.Genomic Biomarkers 6.2.1.Global genomic biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 6.2.2.Global genomic biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 6.3.Protein Biomarkers 6.3.1.Global protein biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 6.3.2.Global protein biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 6.4.Other Biomarkers 6.4.1.Global other biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 6.4.2.Global other biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 7.Cancer/tumor Profiling Market Size and Forecast by Application Cancer/tumor Profiling Market Size and Forecast by Application 7.1.Global Cancer/tumor Profiling market share by application, 2019 & 2027 7.2.Diagnostics 7.2.1.Global Cancer/tumor Profiling market from diagnostics estimates and forecasts, 2016 - 2027 (USD Million) - 6 -

  7. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 7.2.2.Global Cancer/tumor Profiling from diagnostics market estimates and forecasts, by region, 2016 - 2027 (USD Million) 7.3.Prognostics 7.3.1.Global Cancer/tumor Profiling market from Prognostics estimates and forecasts, 2016 - 2027 (USD Million) 7.3.2.Global hard Cancer/tumor Profiling from Prognostics market estimates and forecasts, by region, 2016 - 2027 (USD Million) 7.4.Personalized Medicine 7.4.1.Global Cancer/tumor Profiling market from Personalized Medicine estimates and forecasts, 2016 - 2027 (USD Million) 7.4.2.Global hard Cancer/tumor Profiling from Personalized Medicine market estimates and forecasts, by region, 2016 - 2027 (USD Million) 7.5.Biomarker Discovery 7.5.1.Global Cancer/tumor Profiling market from Biomarker Discovery estimates and forecasts, 2016 - 2027 (USD Million) 7.5.2.Global hard Cancer/tumor Profiling from Biomarker Discovery market estimates and forecasts, by region, 2016 - 2027 (USD Million) 7.6.Research 7.6.1.Global Cancer/tumor Profiling market from Research estimates and forecasts, 2016 - 2027 (USD Million) 7.6.2.Global hard Cancer/tumor Profiling from Research market estimates and forecasts, by region, 2016 - 2027 (USD Million) 8.Cancer/tumor Profiling Market Size and Cancer/tumor Profiling Market Size and Forecast by Region Forecast by Region 8.1.Global cancer/tumor profiling market share by region, 2019 & 2027 8.2.North America 8.2.1.North America cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.2.2.North America cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.2.3.North America cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.2.4.North America cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.2.5.U.S. 8.2.5.1. U.S. cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.2.5.2. U.S. cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.2.5.3. U.S. cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.2.5.4. U.S. cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.2.6.Canada 8.2.6.1. Canada cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.2.6.2. Canada cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.2.6.3. Canada cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 - 7 -

  8. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 8.2.6.4. Canada cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.Europe 8.3.1.Europe cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.2.Europe cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.3.Europe cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.4.Europe cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.5.Germany 8.3.5.1. Germany cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.5.2. Germany cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.5.3. Germany cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.5.4. Germany cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.6.UK 8.3.6.1. UK cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.6.2. UK cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.6.3. UK cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.6.4. UK cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.7.France 8.3.7.1. France cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.7.2. France cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.7.3. France cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.7.4. France cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.8.Italy 8.3.8.1. Ital cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.8.2. Italy cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.8.3. Italy cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.8.4. Italy cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.9.Spain 8.3.9.1. Spain cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.9.2. Spain cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 - 8 -

  9. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 8.3.9.3. Spain cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.9.4. Spain cancer/tumor profiling market by application (USD Million), 2016 – 2027 8.3.10.Netherlands 8.3.10.1.Netherlands cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.10.2.Netherlands cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.10.3.Netherlands cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.10.4.Netherlands cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.4.Asia Pacific 8.4.1.Asia Pacific cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.4.2.Asia Pacific cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.4.3.Asia Pacific cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.4.4.Asia Pacific cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.4.5.China 8.4.5.1. China cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.4.5.2. China cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.4.5.3. China cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.4.5.4. China cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.4.6.South Korea 8.4.6.1. South Korea cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.4.6.2. South Korea cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.4.6.3. South Korea cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.4.6.4. South Korea cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.4.7.Japan 8.4.7.1. Japan cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.4.7.2. Japan cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.4.7.3. Japan cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.4.7.4. Japan cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.4.8.India - 9 -

  10. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 8.4.8.1. India cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.4.8.2. India cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.4.8.3. India cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.4.8.4. India cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.5.Latin America 8.5.1.Latin America cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.5.2.Latin America cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.5.3.Latin America cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.5.4.Latin America cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.5.5.Brazil 8.5.5.1. Brazil cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.5.5.2. Brazil cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.5.5.3. Brazil cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.5.5.4. Brazil cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.5.6.Mexico 8.5.6.1. Mexico cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.5.6.2. Mexico cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.5.6.3. Mexico cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.5.6.4. Mexico cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.5.7.Colombia 8.5.7.1. Colombia cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.5.7.2. Colombia cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.5.7.3. Colombia cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.5.7.4. Colombia cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.6.Middle East & Africa 8.6.1.MEA cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.6.2.MEA cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.6.3.MEA cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.6.4.MEA cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.6.5.Saudi Arabia - 10 -

  11. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 8.6.5.1. Saudi Arabia cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.6.5.2. Saudi Arabia cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.6.5.3. Saudi Arabia cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.6.5.4. Saudi Arabia cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.6.6.South Africa 8.6.6.1. South Africa cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.6.6.2. South Africa cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.6.6.3. South Africa cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.6.6.4. South Africa cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.6.7.Israel 8.6.7.1. Israel cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.6.7.2. Israel cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.6.7.3. Israel cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.6.7.4. Israel cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.6.8.UAE 8.6.8.1. UAE cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.6.8.2. UAE cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.6.8.3. UAE cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.6.8.4. UAE cancer/tumor profiling market by application (USD Million), 2016 - 2027 9.Company Profiles Company Profiles 9.1.Abott Molecular 9.1.1.Overview 9.1.2.Financials 9.1.3.Product Benchmarking 9.1.4.Recent Developments 9.2.Agendia 9.2.1.Overview 9.2.2.Financials 9.2.3.Product Benchmarking 9.2.4.Recent Developments 9.3.Boreal Genomics Inc 9.3.1.Overview 9.3.2.Financials 9.3.3.Product Benchmarking - 11 -

  12. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 9.3.4.Recent Developments 9.4.BD Biosciences 9.4.1.Overview 9.4.2.Financials 9.4.3.Product Benchmarking 9.4.4.Recent Developments 9.5.Caris Life Sciences 9.5.1.Overview 9.5.2.Financials 9.5.3.Product Benchmarking 9.5.4.Recent Developments 9.6.F. Hoffmann-La Roche Ltd 9.6.1.Overview 9.6.2.Financials 9.6.3.Product Benchmarking 9.6.4.Recent Developments 9.7.Foundation Medicine 9.7.1.Overview 9.7.2.Financials 9.7.3.Product Benchmarking 9.7.4.Recent Developments 9.8.Genscript Biotech Corporation 9.8.1.Overview 9.8.2.Financials 9.8.3.Product Benchmarking 9.8.4.Recent Developments 9.9.Guardant Health, Inc. 9.9.1.Overview 9.9.2.Financials 9.9.3.Product Benchmarking 9.9.4.Recent Developments 9.10. Helomics Corporation 9.10.1.Overview 9.10.2.Financials 9.10.3.Product Benchmarking 9.10.4.Recent Developments 9.11. Histogene X 9.11.1.Overview 9.11.2.Financials 9.11.3.Product Benchmarking 9.11.4.Recent Developments 9.12. Hologic, Inc. 9.12.1.Overview 9.12.2.Financials 9.12.3.Product Benchmarking 9.12.4.Recent Developments 9.13. HTG Molecular Diagnostics, Inc. 9.13.1.Overview 9.13.2.Financials 9.13.3.Product Benchmarking - 12 -

  13. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 9.13.4.Recent Developments 9.14. Illumina, Inc. 9.14.1.Overview 9.14.2.Financials 9.14.3.Product Benchmarking 9.14.4.Recent Developments 9.15. Nanostring Technologies, Inc. 9.15.1.Overview 9.15.2.Financials 9.15.3.Product Benchmarking 9.15.4.Recent Developments 9.16. Neogenomics, Inc. 9.16.1.Overview 9.16.2.Financials 9.16.3.Product Benchmarking 9.16.4.Recent Developments 9.17. Omniseq 9.17.1.Overview 9.17.2.Financials 9.17.3.Product Benchmarking 9.17.4.Recent Developments 9.18. Perthera 9.18.1.Overview 9.18.2.Financials 9.18.3.Product Benchmarking 9.18.4.Recent Developments 9.19. Qiagen N.V. 9.19.1.Overview 9.19.2.Financials 9.19.3.Product Benchmarking 9.19.4.Recent Developments 9.20. Ribomed Biotechnologies, Inc. 9.20.1.Overview 9.20.2.Financials 9.20.3.Product Benchmarking 9.20.4.Recent Developments 9.21. Roche Molecular Systems Inc. 9.21.1.Overview 9.21.2.Financials 9.21.3.Product Benchmarking 9.21.4.Recent Developments 9.22. Sysmex Corporation 9.22.1.Overview 9.22.2.Financials 9.22.3.Product Benchmarking 9.22.4.Recent Developments 9.23. Tempus Labs 9.23.1.Overview 9.23.2.Financials 9.23.3.Product Benchmarking - 13 -

  14. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 9.23.4.Recent Developments Access Press Release on Cancer/Tumor Profiling Market: https://www.polarismarketresearch.com/press-releases/cancer-tumor-profiling-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 14 -

More Related